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Abstract 
 
COMPARING THE STRUCTURAL COMPONENTS VARIANCE ESTIMATOR AND U-
STATISTICS VARIANCE ESTIMATOR WHEN ASSESSING THE DIFERENCE BETWEEN 
CORRELATED AUCs WITH FINITE SAMPLES 
 
By Anna Leigh Bosse, M.S. 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
at Virginia Commonwealth University.  
 
Virginia Commonwealth University, 2017 
 
Major Director: Dr. Le Kang, Associate Professor, Department of Biostatistics  
 
Introduction: The structural components variance estimator proposed by DeLong et al. (1988) 
is a popular approach used when comparing two correlated AUCs. However, this variance 
estimator is biased and could be problematic with small sample sizes. 
 
 Methods: A U-statistics based variance estimator approach is presented and compared with the 
structural components variance estimator through a large-scale simulation study under different 
finite-sample size configurations.   
 
Results: The U-statistics variance estimator was unbiased for the true variance of the difference 
between correlated AUCs regardless of the sample size and had lower RMSE than the structural 
components variance estimator, providing better type 1 error control and larger power. The 
structural components variance estimator provided increasingly biased variance estimates as the 
correlation between biomarkers increased. 
 
Discussion: When comparing two correlated AUCs, it is recommended that the U-Statistics 
variance estimator be used whenever possible, especially for finite sample sizes and highly 
correlated biomarkers.  
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Introduction 
 
A biomarker is a measurable indicator of the severity or presence of some specified disease 
state. A diagnostic test uses the observed biomarker value to confirm, or determine whether a 
subject has, or will develop the disease of interest. These tests are useful for early diagnoses, 
disease prevention and drug response. More specifically, biomarkers are essential tools for 
proper diagnosis and treatment of a wide range of illnesses, such as cancer, diabetes and 
infectious diseases [1]. Statistical methods are used to evaluate the overall performance and 
accuracy of these diagnostic tests when the clinical outcome is binary (i.e. diseased or healthy). 
The accuracy of the diagnostic test is based on its ability to correctly separate individuals with 
and without a disease of interest [2]. A Receiver operating characteristic (ROC) curve is a 
graphical plot of the sensitivity versus 1-specificity at each possible threshold or cutoff point of 
the biomarker being assessed, whether it be continuous or ordinal. Sensitivity is the proportion of 
subjects who are correctly identified as having the condition of interest among all subjects who 
truly have the condition (i.e. the true positive rate), whereas specificity is the proportion of 
subjects who are correctly identified as not having the condition of interest among all subjects 
who truly do not have the condition (i.e. the true negative rate). Hence, 1-specificity is the 
proportion of subjects that are incorrectly identified as having the condition of interest among all 
subjects who truly do not have the condition (i.e. the false positive rate). The area under the ROC 
curve (AUC) quantifies the discrimination accuracy of a biomarker. It represents the probability 
that the diagnostic test correctly classifies a randomly selected pair of subjects into their 
 2 
respective groups. To interpret the AUC, first assume there are two groups of subjects that are 
already correctly classified as being either healthy or diseased. Also, assume that higher values 
of some specified biomarker are associated with having the disease of interest, while lower 
values of the specified biomarker are associated with not having the disease of interest. Now 
randomly pick one subject from the diseased group and one subject from the healthy group and 
apply the diagnostic test to both subjects. After evaluating the test on the randomly selected pair, 
the higher biomarker value should correspond to the subject from the diseased group and the 
smaller biomarker value should correspond to the subject from the healthy group. Hence, the 
AUC is the percentage of randomly drawn pairs from these two groups for which this is true (i.e. 
the test correctly classifies the two subjects in the random pair) [2]. An AUC equal to 1 would 
represent a perfect diagnostic test, in which all subjects are correctly classified into the diseased 
and healthy groups based on their observed biomarker measurements. Whereas, an AUC of 0.5 
represents a diagnostic test in which the biomarker has the same ability as random chance in 
discriminating between the diseased and healthy groups (i.e. 50-50 chance). Together, using the 
ROC curve and the AUC as analytical tools, a lot can be said about the performance of a 
particular diagnostic test. 
The growing need for rigorous evaluation of new biomarkers for medical practice has 
spurred the development and characterization of statistical methods for diagnostic accuracy [1].  
ROC and AUC analyses, such as comparing two different biomarkers, can provide useful 
information to researchers in terms of which biomarker is better at classifying subjects with and 
without the disease of interest. To reduce subject-to-subject variation from assessing two 
different biomarkers, the within-subject paired design is usually used, where both biomarkers are 
measured on each subject, thereby resulting in correlated AUCs. For example, Wieand et al. [3] 
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discuss a case-control study that included 90 subjects with pancreatic cancer and 51 subjects 
without pancreatic cancer, but who had pancreatitis. Two different serum biomarkers, both of 
which were measured on a continuous positive scale, were evaluated on each subject. The first 
biomarker was CA-19-9, a carbohydrate antigen, and the second biomarker was CA-125, a 
cancer antigen. The ROC curves and AUCs for both serum biomarkers [1] are presented in 
Figure 1. According to the ROC curves and the AUCs, the CA19-9 biomarker (AUC=0.8614) 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Figure 1. ROC curves for biomarker CA19-9 and CA-125  
                                                                                                                                                                         
appears to perform better than the CA-125 biomarker (AUC=0.7056) as it correctly classifies a 
higher proportion of the subjects (∆=15.58%). In order to determine whether this difference in 
the AUCs for the two serum biomarkers was statistically significant, the null hypothesis, AUCCA-
19-9=AUCCA-125, was assessed. The AUC for the CA-19-9 biomarker was found to be 
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significantly greater than the AUC for the CA-125 biomarker (p=0.0065) [3]. Thus, it can be 
concluded that the carbohydrate antigen biomarker diagnosed pancreatic cancer in patients more 
accurately than the cancer antigen biomarker did. 
Paired sample statistical techniques have been developed for the comparison of two 
biomarkers administered on the same sample population [1]. One of the most popular approaches 
for comparing two correlated AUCs is to create a test statistic using the non-parametric structural 
components variance estimator by Delong et al. [4] along with the asymptotic normality of the 
U-statistics AUC estimator [5] for calculating the difference between two AUCs. The structural 
components variance estimator is equivalent to using the two-sample jackknifing technique and 
provides consistent estimates for the elements of the variance-covariance matrix for U-statistics 
[4]. However, previous research done by Kang et al. [6] demonstrated that this jackknifing based 
variance estimator provided positively biased estimates for the variance of the difference 
between two correlated C-indices for small sample sizes, resulting in inaccurate inferences (i.e. 
power loss and conservative type 1 error control). The C-index is an extension of the AUC 
proposed by Harrell et al. [7] as a measure of concordance between a predictive biomarker and a 
right-censored survival time outcome. This being said, a U-statistics based variance estimator 
[8,6] should always provide unbiased estimates. It is of interest to explore whether the structural 
components variance estimator also provides unbiased estimates for the difference between two 
correlated AUCs with a binary disease outcome. The purpose of this thesis is to: 
1. Review DeLong et al.’s [4] structural components variance estimator and discuss the 
approximations associated with it that may lead to biased estimates for the variance of the 
difference between two correlated AUCs with finite sample sizes. 
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2. Present a U-statistics variance estimator proposed by Chen et al. [8] and discuss how it 
is unbiased for estimating the variance of the difference between two correlated AUCs regardless 
of the sample size. 
3. Conduct large-scale Monte Carlo simulation studies to compare the performance 
between the structural components variance estimator and the U-statistics variance estimator in 
terms of bias and root mean square error (RMSE), as well as to evaluate the type 1 error rates 
and powers associated with the test statistics constructed with respect to each of the two different 
variance estimator approaches. 
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Methods 
 
Suppose there are two different diagnostic tests of interest being assessed on the same 
individuals. Biomarker 1 measurements are taken for each individual for the first diagnostic test 
and biomarker 2 measurements are taken for each individual for the second diagnostic test. 
Suppose that there are N total individuals for which m of them do not have the condition of 
interest (i.e. healthy subjects) and n of them have the condition of interest (i.e. diseased subjects). 
Let Xi and Ui (i=1, 2,…, m) be the healthy subject’s observed biomarker values for diagnostic 
tests 1 and 2, respectively, and let Yj and Vj (j=1, 2, …, n) be the diseased subject’s observed 
biomarker values for diagnostic tests 1 and 2, respectively. From this, we can organize the 
collected data into the following matrix form:  
 
(
 
 
 
 
 
 
𝑂𝑢𝑡𝑐𝑜𝑚𝑒 𝐵𝑖𝑜𝑚𝑎𝑟𝑘𝑒𝑟 1 𝐵𝑖𝑜𝑚𝑎𝑟𝑘𝑒𝑟 2
0 𝑋1 𝑈1
0
⋮
0
1
1
⋮
1
𝑋2
⋮
𝑋𝑚
𝑌1
𝑌2
⋮
𝑌𝑛
𝑈2
⋮
𝑈𝑚
𝑉1
𝑉2
⋮
𝑉𝑛 )
 
 
 
 
 
 
 
Figure 2. Matrix of the observed biomarkers for the Healthy and Diseased Subjects 
 
where each row represents a different subject. Column 1 represents the subject’s status 
(0=healthy, 1=diseased), column 2 represents the observed biomarker values for diagnostic test 1 
and column 3 represents the observed biomarker values for diagnostic test 2. Assuming that 
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higher values of the biomarkers are associated with the subject having the disease and lower 
values of the biomarkers are associated with the subject not having the disease, we can estimate 
the AUC for diagnostic test 1 using the Mann-Whitney U-statistic [4]: 
𝐴𝑈𝐶1̂ =
1
𝑚𝑛
∑∑𝛷(𝑋𝑖, 𝑌𝑗),                                     (1)
𝑛
𝑗=1
𝑚
𝑖=1
 
where 
  𝛷(𝑋, 𝑌) = {  
1        𝑋 < 𝑌
1
2
       𝑋 = 𝑌 
0       𝑋 > 𝑌
}. 
In other words, this average over a kernel estimates the probability that a randomly 
selected subject from the healthy population has a biomarker 1 value less than or equal to a 
randomly selected subject from the diseased population [4]. Note that in regards to probabilities, 
the expected value of the estimated AUC is, E(𝐴𝑈?̂?)=AUC=Pr(X<Y)+
1
2
Pr(X=Y), where 
Pr(X=Y) = 0 for continuous distributions [4]. The estimated AUC for the diagnostic test 2 
(𝐴𝑈𝐶2)̂  can be calculated using equation 1 and replacing Xi and Yj with Ui and Vj, respectively. 
Now, in order to compare the two correlated diagnostic tests, the difference between two AUCs 
can be calculated by: 
∆AUĈ =
1
𝑚𝑛
∑∑[𝛷(𝑋𝑖 , 𝑌𝑗) − 𝛷(𝑈𝑖, 𝑉𝑗)]
𝑛
𝑗=1
𝑚
𝑖=1
 
                    =
1
𝑚𝑛
∑∑𝛿(𝑋𝑖,
𝑛
𝑗=1
𝑚
𝑖=1
𝑌𝑗 , 𝑈𝑖, 𝑉𝑗),                (2) 
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where a kernel δ(𝑋, 𝑌,𝑈, 𝑉) = [𝛷(𝑋, 𝑌) − 𝛷(𝑈, 𝑉)]. For simplification purposes, we will use 
δ(𝑋𝑖, 𝑌𝑗,𝑈𝑖 , 𝑉𝑗) and 𝛿𝑖𝑗 interchangeably. The true variance for the estimated difference between the 
two correlated AUCs (See Appendix A) can be expressed as: 
𝑣𝑎𝑟(∆AUĈ) = 𝑣𝑎𝑟 (
1
𝑚𝑛
∑∑𝛿𝑖𝑗 
𝑛
𝑗=1
𝑚
𝑖=1
) 
=
(𝑚 − 1)𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖`𝑗] + (𝑛 − 1)𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗`] + 𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗]
𝑚𝑛
, i` ≠  i, j` ≠ j.              (3) 
 
Structural Components Variance Estimator 
 
Delong et al. [4] estimated cov[𝛿𝑖𝑗,𝛿𝑖`𝑗] and cov[𝛿𝑖𝑗,𝛿𝑖𝑗`] using a method of structural 
components by Sen [9], and disregarded the term cov[𝛿𝑖𝑗,𝛿𝑖𝑗] since it converges to zero faster than 
the first two terms. The difference kernel matrix, [𝛿𝑖𝑗]mxn, in Figure 3 shows the kernel differences 
between the two biomarkers for each of the different combinations of subjects. 
(
δ(𝑋1, 𝑌1, 𝑈1, 𝑉1) ⋯ δ(𝑋1, 𝑌𝑛, 𝑈1, 𝑉𝑛)
⋮ ⋱ ⋮
δ(𝑋𝑚, 𝑌1, 𝑈𝑚, 𝑉1) ⋯ δ(𝑋𝑚, 𝑌𝑛, 𝑈𝑚, 𝑉𝑛)
)
𝑚𝑥𝑛
 
        Figure 3. Difference kernel matrix 
 
The row (R) and column (C) components, which are row and column marginal means of 
the difference kernel matrix, [𝛿𝑖𝑗]mxn, are defined as: 
𝑅𝑖 =
1
𝑛
∑𝛿𝑖𝑗 , 𝑖 = 1,2, …𝑚,
𝑛
𝑗=1
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and       
𝐶𝑗 =
1
𝑚
∑𝛿𝑖𝑗 , 𝑗 = 1,2, … 𝑛,
𝑚
𝑖=1
 
respectively. Then the structural components estimator for cov[𝛿𝑖𝑗,𝛿𝑖`𝑗] is  
𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖`𝑗] =
1
𝑛 − 1
∑(𝐶𝑗 − 𝐶̅)
2
𝑛
𝑗=1
, 
and the structural components estimator for cov[𝛿𝑖𝑗,𝛿𝑖𝑗`] is 
𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖𝑗`] =
1
𝑚 − 1
∑(𝑅𝑖 − ?̅?)
2
𝑚
𝑖=1
, 
where 𝐶̅ = ?̅? =  
1
𝑚𝑛
∑ ∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1 =∆AUĈ. Therefore, the structural components variance estimator 
for the true var(∆AUĈ) proposed by DeLong et al. [4] is, 
𝑣𝑎?̂?(∆AUĈ) =
𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖`𝑗]
𝑛
+
𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖𝑗`]
𝑚
.                         (4) 
Further details regarding the construction of the structural components variance estimator 
can be seen in DeLong et al. [4]. There are a few approximations linked with the Structural 
Components variance estimator in equation (4) that induce bias when estimating the true 
var(∆AUĈ) for finite sample sizes. In Appendix B, it is shown that both of the structural 
components estimators for 𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖`𝑗] and 𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖𝑗`] are biased. Not only does the 
DeLong et al.’s structural components variance estimator ignore the term 
𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗] 
𝑚𝑛
, but it also 
increases the values of 
𝐶𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖`𝑗]
𝑛
 and 
𝐶𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗`]
𝑚
 by substituting 
𝑚−1
𝑚
 and 
𝑛−1
𝑛
 with 1. The bias 
associated with the structural components variance estimator in equation (4) is quantified in 
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Appendix C.  Despite its biasedness, the structural components variance estimator is consistent, 
meaning it could be satisfactory when used with large sample sizes. To show this, the expectations 
of the structural components estimators for 𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖`𝑗] and 𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖𝑗`] were taken, and then 
the limit as the sample sizes, m and n, approached infinity were assessed (See Appendix B). As m 
 ∞, 
𝑚−1
𝑚
  1 and as n  ∞, 
𝑛−1
𝑛
  1, but for finite sample sizes, these values would be distinctly 
less than 1. Therefore, the structural components variance estimator could be potentially 
problematic with smaller sample sizes, causing biased variance estimates for the difference 
between two correlated AUCs. However, note that the direction of this possible bias is not obvious 
due to the combination of the non-negative term, 
𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗] 
𝑚𝑛
, being disregarded and the terms, 
𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖`𝑗] and 𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖𝑗`], being amplified in value for finite sample sizes. 
 
U-Statistics Variance Estimator  
 
In order to present a completely unbiased estimator for the true var(∆AUĈ), it is imperative 
to not only create unbiased estimators for 𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖`𝑗] and 𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗`], but also for 𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗]. 
Chen et al. [8] developed a U-statistics based estimators that are unbiased for the three 
previously mentioned covariance terms, which are shown below: 
𝑐𝑜?̂?𝑈[𝛿𝑖𝑗,𝛿𝑖`𝑗] =  ∑∑∑
𝛿𝑖𝑗𝛿𝑖`𝑗
𝑚𝑛(𝑚 − 1)
𝑚
𝑖`≠𝑖
𝑛
𝑗=1
𝑚
𝑖=1
− ∑∑∑ ∑
𝛿𝑖𝑗𝛿𝑖`𝑗`
𝑚𝑛(𝑚 − 1)(𝑛 − 1)
,
𝑛
𝑗`≠𝑗
𝑚
𝑖`≠𝑖
𝑛
𝑗=1
𝑚
𝑖=1
 
𝑐𝑜?̂?𝑈[𝛿𝑖𝑗,𝛿𝑖𝑗`] =  ∑∑ ∑
𝛿𝑖𝑗𝛿𝑖𝑗`
𝑚𝑛(𝑛 − 1)
𝑛
𝑗`≠𝑗
𝑛
𝑗=1
𝑚
𝑖=1
− ∑∑∑ ∑
𝛿𝑖𝑗𝛿𝑖`𝑗`
𝑚𝑛(𝑚 − 1)(𝑛 − 1)
,
𝑛
𝑗`≠𝑗
𝑚
𝑖`≠𝑖
𝑛
𝑗=1
𝑚
𝑖=1
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𝑐𝑜?̂?𝑈[𝛿𝑖𝑗,𝛿𝑖𝑗] =  ∑∑
𝛿𝑖𝑗
2
𝑚𝑛
𝑛
𝑗=1
𝑚
𝑖=1
− ∑∑∑ ∑
𝛿𝑖𝑗𝛿𝑖`𝑗`
𝑚𝑛(𝑚 − 1)(𝑛 − 1)
.
𝑛
𝑗`≠𝑗
𝑚
𝑖`≠𝑖
𝑛
𝑗=1
𝑚
𝑖=1
 
After substituting these unbiased estimators for the covariance terms into equation (3) and 
simplifying, an unbiased U-statistics based estimator for the true var(∆AUĈ) is obtained, 
𝑣𝑎𝑟(̂∆AUĈ) =  ∑∑ ∑ ∑
𝛿𝑖𝑗𝛿𝑖`𝑗`
𝑚2𝑛2
𝑛
𝑗`=1
𝑚
𝑖`=1
𝑛
𝑗=1
𝑚
𝑖=1
− ∑∑∑ ∑
𝛿𝑖𝑗𝛿𝑖`𝑗`
𝑚𝑛(𝑚 − 1)(𝑛 − 1)
𝑛
𝑗`≠𝑗
𝑚
𝑖`≠𝑖
𝑛
𝑗=1
𝑚
𝑖=1
 
                                    = (∑∑
𝛿𝑖𝑗
𝑚𝑛
𝑛
𝑗=1
𝑚
𝑖=1
)
2
− ∑∑∑ ∑
𝛿𝑖𝑗𝛿𝑖`𝑗`
𝑚𝑛(𝑚 − 1)(𝑛 − 1)
𝑛
𝑗`≠𝑗
𝑚
𝑖`≠𝑖
𝑛
𝑗=1
.
𝑚
𝑖=1
                   (5) 
Further, using the formula for the variance of a discrete random variable, X, defined by 
Var(X)=E(X2) – (E(X))2, we get the following for the variance of the difference between two 
correlated AUC’s in terms of expectations: 
𝑣𝑎𝑟(∆AUĈ) =  𝐸 [(
1
𝑚𝑛
∑∑𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
)
2
] − [𝐸 (
1
𝑚𝑛
∑∑𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
)]
2
. 
Hence, a natural unbiased estimator would be: 
𝑣𝑎𝑟(̂∆AUĈ) =  (
1
𝑚𝑛
∑∑𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
)
2
− (
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
)
(
 
 1
(𝑚 − 1)(𝑛 − 1)
∑ ∑ 𝛿𝑖`𝑗`
𝑛
𝑗`=1
𝑗`≠𝑗
𝑚
𝑖`=1
𝑖`≠𝑖
)
 
 
, 
which is the same estimator as the one shown in equation (5). Thus, this U-statistics based 
variance estimator is always unbiased for the true var(∆AUĈ) regardless of the sample size (See 
Appendix D).  
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Proposed Comparison and Simulation Study 
 
To evaluate the effectiveness of the proposed U-statistics variance estimator against the 
widely used structural components variance estimator for the difference between two correlated 
AUCs, several Monte Carlo (MC) simulation studies were conducted in R to compare the 
relative bias and relative RMSE of the two different variance estimator approaches. For all 
subjects, the true biomarker values for diagnostic tests 1 and 2 were generated from a bivariate 
normal distribution with pre-specified means, standard deviations and correlations. More 
specifically, the healthy subject’s (m) biomarker values were simulated from 𝐻~𝑁2(µ, 𝜮) where 
µ=(0,0)T and Σ=(
1 𝑝
𝑝 1
) (i.e. N(0,1)) and the diseased subject’s (n) biomarker values were 
simulated from 𝐷~𝑁2(µ, 𝜮) where µ=(µ1, µ2)
T and Σ=(
𝜎1
2 𝑝𝜎1𝜎2
𝑝𝜎1𝜎2 𝜎2
2 )  (See Appendix E). The 
correlation coefficient, 𝑝, was set to 0.1, 0.5 and 0.9 to introduce different correlations between 
the two AUCs. Note that the same correlation coefficient, 𝑝, was used for both the diseased and 
healthy populations in each of the different sample size scenarios. The AUCs for diagnostic tests 
1 and 2 were altered by setting the diseased population’s mean and standard deviation 
parameters, µ1, µ2, 𝜎1 and 𝜎2, to fixed values using the following formula: AUC=Φ(
µ𝐷−µ𝐻
√𝜎𝐷
2+𝜎𝐻
2
) 
[10], where the true ∆AUC=0, 0.1 or 0.2. The finite total sample sizes, 𝑛𝑇=m+n, that were 
assessed included 20, 30, 40, 50 and 60 subjects. Different ratios of healthy subjects versus 
diseased subjects were explored, including a balanced design (m:n=1:1), as well as unbalanced 
designs (m:n=1:2 or 1:3). If based on the total sample size, a ratio resulted in a fraction for the 
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healthy and diseased sample sizes, then the values were rounded. For example, a sample size of 
20 and a size ratio of 1:2, results in 6.67 healthy subjects and 13.33 diseased subjects. Therefore, 
for our simulation, the healthy sample size was rounded up to 7 subjects and the diseased sample 
size was rounded down to 13 subjects. For each of the scenarios involving different total sample 
sizes, size ratios, correlations, and mean/standard deviation parameters for the diseased subjects, 
the data was sampled and the Mann-Whitney U-statistic for ∆AUĈ was estimated. Afterwards, 
the structural components variance estimator and the U-statistics variance estimator were applied 
for estimating the true 𝑣𝑎𝑟(∆AUĈ). Each of the different scenarios were simulated (nsim) 
100,000 times, resulting in 100,000 ∆AUĈ estimates and 100,000 Structural Components and U-
statistics variance estimates (𝑣𝑎?̂?(∆AUĈ)) each. The true 𝑣𝑎𝑟(∆AUĈ) was computed by taking 
the sample variance of the 100,000 estimated ∆AUĈ. Using these estimated values, the Relative 
Bias (1) and Relative RMSE (2) for both variance estimator approaches were calculated as:  
(1) Relative Bias =  
𝐵𝑖𝑎𝑠
 𝑣𝑎𝑟(∆AUĈ)
 X 100%, where Bias = 
∑ (𝑣𝑎𝑟(̂ ∆AUĈ)−𝑣𝑎𝑟(∆AUĈ))𝑛𝑖=1
𝑛
   
and 
 (2) Relative RMSE =  
𝑅𝑀𝑆𝐸
𝑣𝑎𝑟(∆AUĈ)
 X 100%, where RMSE =  √
∑ (𝑣𝑎?̂?(∆AUĈ)−𝑣𝑎𝑟(∆AUĈ))2𝑛𝑖
𝑛
.  
Additionally, through MC simulation studies in R, we also investigated the empirical type 
1 error rates and powers for both methods by conducting hypothesis testing through the test 
statistic Z = 
∆AUĈ
√𝑣𝑎?̂?(∆AUC)̂
 , where the numerator is the estimated difference in the AUC of the two 
diagnostic tests and the denominator is either the structural components variance estimate (i.e. 
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DeLong’s Test) or the U-statistics variance estimate (i.e. U-stats Test). The reference 
distributions for both the DeLong’s test statistic and the U-stats test statistic are the standard 
normal due to the asymptotic normality of the Mann-Whitney U-statistic [4,6] for the estimated 
difference in AUC (∆AUC)̂ . The null hypothesis was that there is no difference in the diagnostic 
ability of the two diagnostic tests (∆AUC=0) and the significance level was set to α=0.05. Again, 
each of the different scenarios were simulated 100,000 times, resulting in 100,000 p-values for 
both the DeLong’s test and the U-stats test. To get the empirical type 1 error rates and powers for 
each of the different scenarios, the average number of p-values < α=0.05 was calculated 
(
∑ 𝑃−𝑣𝑎𝑙𝑢𝑒𝑖<0.05
𝑛𝑠𝑖𝑚=100,00
𝑖=1
𝑛𝑠𝑖𝑚
). Note that when the true ∆AUC=0, the result was the empirical type 1 
error rate (i.e. false positive rate) and when the true ∆AUC≠0, the result was the empirical power 
(i.e. correctly reject the null hypothesis when the alternative that the two AUC’s are different is 
true). The R code with the functions corresponding to the procedures described are available in 
Appendix F and G. 
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Results 
 
Tables 1-6 show the relative bias and relative RMSE for both the Structural Components 
variance estimator and the U-statistics variance estimator under different sample-size 
configurations. Note that, in the tables, the columns without parenthesis represent the relative 
bias and the columns with the parenthesis represent the relative RMSE. In Tables 1-3, the true 
AUC for diagnostic tests 1 and 2 are both set equal to 0.9, 0.8 and 0.7, respectively (i.e. 
∆AUC=0). Tables 1-3 show the same overall general patterns for both the relative bias and 
relative RMSE and are summarized as follows. First, the U-statistics variance estimator was 
almost always unbiased (≈0%) for all of the total sample sizes, size ratios and varying 
correlations, while the structural components variance estimator was always biased (2%-31%). 
While the relative bias decreased as the sample size increased for the structural components 
variance estimator, it is imperative to point out the problematic increase in relative bias as the 
correlation between the two AUC’s increased from 𝑝=0.1 to 𝑝=0.9. For example, when 
AUC1=AUC2=0.9, µ1=1.8124, µ2=2.2049, σ1=1, σ2=1.4, m:n=1:1 and nT=20, the relative bias is 
9% when 𝑝=0.1 and 25% when 𝑝=0.9 (Table 1). Similarly, for the same scenario, except when 
nT=60, the relative bias is 3% when 𝑝=0.1 and 10% when 𝑝=0.9. In addition, the relative RMSE 
for the U-statistsics variance estimator is always equal to or less than the structural components 
variance estimator in all of the scenarios. While the relative RMSE decreased as the total sample 
size increased for both variance estimator approaches, the relative RMSE increased as the 
correlation between the two AUC’s increased from 𝑝=0.1 to 𝑝=0.9 for both approaches. 
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However, this increase in relative RMSE was more severe for the structural components variance 
estimator as compared to the U-statistics variance estimator. For example, in Table 3, 
AUC1=AUC2=0.7 (∆AUC=0), µ1=0.7416, µ2=0.6401, σ1=1, σ2=0.7, m:n=1:2 and nT=20, the 
relative RMSE for the structural components variance estimator was 44% when 𝑝=0.1 and 76% 
when 𝑝=0.9 (∆=32%). Whereas, the relative RMSE for the U-Statistics variance estimator was 
44% when 𝑝=0.1 and 70% when 𝑝=0.9 (∆=26%). It can be noted that as the total sample size 
increased within each of the size ratios, the quantitative increase in relative RMSE from 𝑝=0.1 to 
𝑝=0.9 became more similar for both variance estimator approaches. Using the same parameters 
listed previously except with nT=60, the relative RMSE for the structural components variance 
estimator was 24% when 𝑝=0.1 and 40% when 𝑝=0.9 (∆=16%), whereas the relative RMSE for 
the U-Statistics variance estimator was 24% when 𝑝=0.1 and 38% when 𝑝=0.9 (∆=14%). Hence, 
the difference in the increase of the relative RMSE between the structural components variance 
estimator and the U-statistics variance estimator decreased from 6% to 2% when the total sample 
size increased from 20 to 60. In Tables 4-5 (∆AUC=0.1) and Table 6 (∆AUC=0.2), the same 
trends are found regarding the bias and RMSE. That is, that under all of the scenarios presented, 
the U-statistics variance estimator was almost always unbiased and had smaller RMSE than the 
structural components variance estimator, while the bias associated with the structural 
components variance estimator increased as the correlation between AUCs increased. 
Tables 7-12 show the empirical type 1 error rates and powers for both the structural 
components variance estimator and the U-Statistics variance estimator under the same scenarios 
presented in Tables 1-6 above, respectively. More specifically, Tables 7-9 show the empirical 
type 1 error rates when the true ∆AUC=0 (AUC1=AUC2=0.9, 0.8, and 0.7 respectively) and 
Tables 10-12 show the empirical powers when the true ∆AUC≠0 (∆AUC=0.1 and 0.2). The U-
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stats test gives a more accurate type 1 error control as compared to the DeLong’s test, especially 
for highly correlated AUCs. This makes sense intuitively because the positive bias from the 
structural components variance estimator causes a larger denominator in the test statistic 
(√𝑣𝑎?̂?(∆AUC)̂ ) than is expected, leading to a smaller Z and ultimately, a more conservative 
type 1 error. For example, in Table 8 when AUC1=AUC2=0.8 (∆AUC=0), µ1=µ2=1.1902, 
σ1=σ2=1, m:n=1:1, nT=30 and 𝑝=0.9 the empirical type 1 error rate for the DeLong’s test is 
0.0265, while the empirical type 1 error rate for the U-stats test is 0.0497. For the same scenario, 
except this time with size ratio m:n=1:3, the empirical type 1 error rate for the DeLong’s test is 
0.0259, while the empirical type 1 error rate for the U-stats test is 0.0536. The same overall 
pattern of better type 1 error control for the U-stats test versus the DeLong’s test are seen in 
Tables 7 and 9. In addition, the U-stats test also gives larger power as compared to the DeLong’s 
test. Again, the positive bias from the structural components variance estimator causes a larger 
denominator than it should be in the Z-test statistic leading to power loss. For example, in Table 
10 when AUC1= 0.8, AUC2=0.9, ∆AUC=0.1, µ1= 1.1902, µ2=2.2049, σ1=1, σ2=1.4, m:n=1:2, 
nT=20 and 𝑝=0.9 the empirical power for the DeLong’s test is 0.1610, while the empirical power 
for the U-Stats test is 0.2595. For the same sceneraio, except this time with nT=40, the empirical 
power for the DeLong’s test is 0.5804, while the empirical power for the U-stats test is 0.6480. 
The same overall pattern of larger power for the U-stats test vs. the DeLong’s test is shown in 
supplementary Table 11 where the ∆AUC is also equal to 0.1. Finally, in Table 12 when AUC1= 
0.7, AUC2=0.9, ∆AUC=0.2, µ1= 0.7416, µ2=1.8124, σ1=σ2=1, m:n=1:3, nT=20 and 𝑝=0.9, the 
empirical power for the DeLong’s test is 0.5015, while the empirical power for the U-Stats test is 
0.6105. For the same sceneraio, except this time with size ratio m:n=1:1, the empirical power for 
the DeLong’s test is 0.6875, while the empirical power for the U-stats test is 0.7709. It is evident 
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that for smaller sample sizes and highly correlated AUCs, the U-stats test provides better overall 
type 1 error control (i.e. closer to the pre-specified α=0.05), as well as larger power for all 
scenarios considered in the simulation study. 
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Table 1. Relative Bias and RMSE for DeLong and U-statistics variance estimators (nsim=100,000, AUC) 
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Table 2. Relative Bias and RMSE for DeLong and U-statistics variance estimators (nsim=100,000) 
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Table 3. Relative Bias and RMSE for DeLong and U-statistics variance estimators (nsim=100,000) 
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Table 4. Relative Bias and RMSE for DeLong and U-statistics variance estimators (nsim=100,000) 
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Table 5. Relative Bias and RMSE for DeLong and U-statistics variance estimators (nsim=100,000) 
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Table 6. Relative Bias and RMSE for DeLong and U-statistics variance estimators (nsim=100,000) 
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Table 7. Type I error rates for comparing two correlated AUCs (nsim=100,000) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 26 
Table 8. Type I error rates for comparing two correlated AUCs (nsim=100,000) 
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Table 9. Type I error rates for comparing two correlated AUCs (nsim=100,000) 
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Table 10. Powers for comparing two correlated AUCs (nsim=100,000) 
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Table 11. Powers for comparing two correlated AUCs (nsim=100,000) 
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Table 12. Powers for comparing two correlated AUCs (nsim=100,000) 
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Discussion 
 
In this paper, we discussed using a U-statistics based variance estimator rather than the 
commonly used DeLong’s structural components variance estimator when evaluating the 
difference between two correlated AUCs with finite samples. Ultimately, the U-statistics 
variance estimator approach is recommended in order to get more accurate inference for 
determining whether or not there is a difference in the diagnostic ability of two biomarkers being 
measured on the same subjects when the sample sizes are small. Under different finite sample 
sizes of healthy and diseased subjects, size ratios, and levels of correlations between two 
biomarkers, the relative bias and relative RMSE affiliated with both variance estimators were 
compared. The U-statistics variance estimator was found to be unbiased, as well as to have lower 
RMSE than the structural components variance estimator. We also showed mathematically, that 
the U-statistics based variance estimator is unbiased for the true var(∆AUĈ) regardless of the 
sample size, as well as quantified the bias associated with the structural components variance 
estimator. Under the same scenarios used for comparing the bias and RMSE for the two variance 
estimator approaches, we also constructed a test statistic based on both the U-statistics variance 
estimator and the structural components variance estimator and found that the U-stats test 
produced much more precise type 1 error control and larger power as compared to the DeLong’s 
test. This demonstrated that the positive bias from the structural components variance estimator 
affected the type 1 error rate and power associated with the DeLong’s test statistic. Therefore, 
the U-statistics based estimator not only provides a more accurate estimate for the variance of the 
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difference between two correlated AUC’s, but it also provides better statistical inference 
regarding the difference in diagnostic ability of two biomarkers measured on the same 
individuals.  
This being said, the U-statistics variance estimator and the structural components variance 
estimator are asymptotically equivalent, meaning that the DeLong’s test could be suitable for 
instances when the sample size is large and/or the correlations between biomarkers are small. 
Despite this point, the structural components variance estimator’s poor performance with finite 
sample sizes suggests that the U-statistics based variance estimator should be used whenever 
feasible to compare the difference between two correlated AUCs. For example, in the early 
stages of studies or clinical trials, the sample sizes are usually small. Thus, by using the U-
statistics variance estimator, the researchers would be able to make more accurate conclusions 
and get better insight about how one biomarker is performing against another earlier in the 
clinical trial process.  
A limitation of this work is that the biomarker values for the healthy and diseased subjects 
were only simulated from normal distributions. For future work, it would be useful to consider 
simulating biomarker values from different non-normal continuous probability distributions, 
such as a t-distribution, chi-squared distribution or an F-distribution to see if the same patterns 
and results hold true regarding the performance of the U-statistics and structural components 
variance estimators. Similar results would be expected as the test statistic is non-parametric and 
thus, should be robust. In addition, only biomarkers on a continuous scale were addressed. For 
future work, it would also be useful to assess these two different variance estimator approaches 
on biomarkers that are based on an ordinal scale, such as the Likert scale. Another limitation is 
that the same correlation value for both the diseased and healthy subjects was assumed when 
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simulating data. Often times, the correlation between biomarkers for the healthy subjects is 
different than the correlation between biomarkers for the diseased subjects and so these scenarios 
should also be explored in the future. Finally, it would be beneficial to apply and compare the 
performances of both the U-statistic and structural components variance estimators on a real 
medical dataset to demonstrate its practical application in a real-world study setting.  
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Appendix A 
 
The following shows the calculations for finding the true var(∆AUĈ). 
 
var(∆AUĈ) = var(
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
) =  
1
𝑚2𝑛2
var(∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
) 
=
1
𝑚2𝑛2
 [𝐸 (∑∑ 𝛿𝑖𝑗
2
𝑛
𝑗=1
𝑚
𝑖=1
) − 𝐸 (∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
)
2
]             𝑛𝑜𝑡𝑒: 𝑣𝑎𝑟(𝑋) = 𝐸(𝑋2) − 𝐸(𝑋)2 
 
=
1
𝑚2𝑛2
[𝐸 (∑∑ ∑ ∑ 𝛿𝑖𝑗𝛿𝑖`𝑗`
𝑛
𝑗`=1
𝑚
𝑖`=1
𝑛
𝑗=1
𝑚
𝑖=1
) − 𝐸 (∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
)𝐸 (∑∑ 𝛿𝑖`𝑗`
𝑛
𝑗=1
𝑚
𝑖=1
)] 
 
=
1
𝑚2𝑛2
[𝑐𝑜𝑣 (∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
, ∑ ∑  𝛿𝑖`𝑗`
𝑛
𝑗`=1
𝑚
𝑖`=1
)]                         𝑛𝑜𝑡𝑒: 𝑐𝑜𝑣(𝑋, 𝑌) = 𝐸(𝑋𝑌) − 𝐸(𝑋)𝐸(𝑌) 
 
= cov (
𝛿11 + 𝛿12 + ⋯ + 𝛿1𝑛 𝛿11 + 𝛿12 + ⋯+ 𝛿1𝑛
𝛿21 + 𝛿22 + ⋯ + 𝛿2𝑛 𝛿21 + 𝛿22 + ⋯+ 𝛿2𝑛
⋮ ⋮
𝛿𝑚1 + 𝛿𝑚2 + ⋯+ 𝛿𝑚𝑛     , 𝛿𝑚1 + 𝛿𝑚2 + ⋯+ 𝛿𝑚𝑛
)
𝑚𝑥𝑛
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= 𝑚𝑛 {
𝑐𝑜𝑣(𝛿11, 𝛿11) + 𝑐𝑜𝑣(𝛿11, 𝛿12) + ⋯+ 𝑐𝑜𝑣(𝛿11, 𝛿𝑚𝑛)
𝑐𝑜𝑣(𝛿12, 𝛿11) + 𝑐𝑜𝑣(𝛿12, 𝛿12) + ⋯+ 𝑐𝑜𝑣(𝛿12, 𝛿𝑚𝑛)
⋮
𝑐𝑜𝑣(𝛿𝑚𝑛, 𝛿11) + 𝑐𝑜𝑣(𝛿𝑚𝑛, 𝛿12) + ⋯+ 𝑐𝑜𝑣(𝛿𝑚𝑛, 𝛿𝑚𝑛)
 
 
=
𝑚𝑛𝑐𝑜𝑣(𝛿𝑖𝑗 , 𝛿𝑖𝑗) + 𝑚𝑛(𝑚 − 1)𝑐𝑜𝑣(𝛿𝑖𝑗, 𝛿𝑖`𝑗) + 𝑚𝑛(𝑛 − 1)𝑐𝑜𝑣(𝛿𝑖𝑗 , 𝛿𝑖𝑗`)
𝑚𝑛2
 
After simplifying, we get: 
𝑣𝑎𝑟(∆AUĈ) =
𝑐𝑜𝑣(𝛿𝑖𝑗 , 𝛿𝑖𝑗) + (𝑚 − 1)𝑐𝑜𝑣(𝛿𝑖𝑗 , 𝛿𝑖`𝑗) + (𝑛 − 1)𝑐𝑜𝑣(𝛿𝑖𝑗, 𝛿𝑖𝑗`)
𝑚𝑛
. 
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Appendix B 
 
Below shows that the structural components variance estimator is consistent, but not 
unbiased. 
 
We first consider the structural components variance estimator for cov[𝛿𝑖𝑗,𝛿𝑖`𝑗], i.e., 
𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖`𝑗] =
1
𝑛 − 1
∑(𝐶𝑗 − 𝐶̅)
2
𝑛
𝑗=1
 
Recognize that, 
𝐸(𝐶𝑗
2) = 𝐸 {(
1
𝑚
∑𝛿𝑖𝑗
𝑚
𝑖=1
)
2
} =  
1
𝑚2
∑ ∑ 𝐸(𝛿𝑖𝑗𝛿𝑖`𝑗
𝑚
𝑖`=1
𝑚
𝑖=1
) =
1
𝑚2
∑ ∑[𝑐𝑜𝑣(𝛿𝑖𝑗, 𝛿𝑖`𝑗) + (∆AUC)
2]
𝑚
𝑖`=1
𝑚
𝑖=1
 
      
   =
𝑐𝑜𝑣(𝛿𝑖𝑗,𝛿𝑖𝑗)+(𝑚−1)𝑐𝑜𝑣(𝛿𝑖𝑗,𝛿𝑖`𝑗)
𝑚
 + (∆AUĈ)2, i≠i`, 
 
𝐸(𝐶𝑗𝐶̅) = 𝐸 {(
1
𝑚
∑𝛿𝑖𝑗
𝑚
𝑖=1
)(
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
)} = 
1
𝑚2𝑛
∑ ∑ ∑ 𝐸(
𝑛
𝑗`=1
𝑚
𝑖`=1
𝑚
𝑖=1
𝛿𝑖𝑗𝛿𝑖`𝑗`) 
   
=
1
𝑚2𝑛
∑ ∑ ∑[𝑐𝑜𝑣(𝛿𝑖𝑗, 𝛿𝑖`𝑗`) + (∆AUC)
2]
𝑛
𝑗`=1
𝑚
𝑖`=1
𝑚
𝑖=1
 
      
=
𝑐𝑜𝑣(𝛿𝑖𝑗,𝛿𝑖𝑗)+(𝑚−1)𝑐𝑜𝑣(𝛿𝑖𝑗,𝛿𝑖`𝑗)+(𝑛−1)𝑐𝑜𝑣(𝛿𝑖𝑗,𝛿𝑖𝑗`)
𝑚𝑛
 + (∆AUC)2, i≠i`, j≠j`, 
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𝐸(𝐶̅2) = 𝐸 {(
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
)
2
} =
1
𝑚2𝑛2
∑∑ ∑ ∑ 𝐸(𝛿𝑖𝑗𝛿𝑖`𝑗`)
𝑛
𝑗`=1
𝑚
𝑖`=1
𝑛
𝑗=1
𝑚
𝑖=1
 
=
1
𝑚2𝑛2
∑∑ ∑ ∑[𝑐𝑜𝑣(𝛿𝑖𝑗 , 𝛿𝑖`𝑗`) + (∆AUC)
2 ]
𝑛
𝑗`=1
𝑚
𝑖`=1
𝑛
𝑗=1
𝑚
𝑖=1
 
=
𝑐𝑜𝑣(𝛿𝑖𝑗,𝛿𝑖𝑗)+(𝑚−1)𝑐𝑜𝑣(𝛿𝑖𝑗,𝛿𝑖`𝑗)+(𝑛−1)𝑐𝑜𝑣(𝛿𝑖𝑗,𝛿𝑖𝑗`)
𝑚𝑛
 + (∆AUC)2, i≠i`, j≠j`. 
 
Therefore,  
𝐸(𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖`𝑗]) = 𝐸 {
1
𝑛 − 1
∑(𝐶𝑗 − 𝐶̅)
2
𝑛
𝑗=1
} = 
1
𝑛 − 1
∑𝐸(
𝑛
𝑗=1
𝐶𝑗
2 − 2𝐶𝑗𝐶̅  +  𝐶̅
2) 
           = 
𝑚−1
𝑚
𝑐𝑜𝑣[𝛿𝑖𝑗, 𝛿𝑖`𝑗] +
1
𝑚
𝑐𝑜𝑣[𝛿𝑖𝑗 , 𝛿𝑖𝑗] −
1
𝑚
𝑐𝑜𝑣[𝛿𝑖𝑗, 𝛿𝑖𝑗`] 
            𝑐𝑜𝑣[𝛿𝑖𝑗, 𝛿𝑖`𝑗] as m  ∞ 
Similarly,  
 
𝐸(𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖𝑗`]) = 𝐸 {
1
𝑚 − 1
∑(𝑅𝑖 − ?̅?)
2
𝑚
𝑖=1
} =  
1
𝑚 − 1
∑𝐸(
𝑚
𝑖=1
𝑅𝑖
2 − 2𝑅𝑖?̅?  +  ?̅?
2) 
          = 
𝑛−1
𝑛
𝑐𝑜𝑣[𝛿𝑖𝑗, 𝛿𝑖𝑗`] +
1
𝑛
𝑐𝑜𝑣[𝛿𝑖𝑗, 𝛿𝑖𝑗] −
1
𝑛
𝑐𝑜𝑣[𝛿𝑖𝑗 , 𝛿𝑖`𝑗] 
     𝑐𝑜𝑣[𝛿𝑖𝑗, 𝛿𝑖𝑗`] as n  ∞ 
Hence, the structural components variance estimator used by DeLong et al. is consistent, 
but not unbiased. 
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Appendix C 
 
Below shows the bias that is associated with the structural components variance estimator. 
 
By taking the expectation of DeLong et al.’s structural components variance estimator in 
equation (4) we get: 
𝐸[𝑣𝑎?̂?(∆AUC)̂ ] =
𝐸(𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖`𝑗])
𝑛
+
𝐸(𝑐𝑜𝑣𝑆?̂?[𝛿𝑖𝑗,𝛿𝑖𝑗`])
𝑚
 
= 
𝑚−1
𝑚
𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖`𝑗]+
1
𝑚
𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗]−
1
𝑚
𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗`]
𝑛
 + 
𝑛−1
𝑛
𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗`]+
1
𝑛
𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗]−
1
𝑛
𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖`𝑗]
𝑚
 
= 
2𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗]+(𝑚−2)𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖`𝑗]+(𝑛−2)𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗`]
𝑚𝑛
, 𝑖 ≠ 𝑖`, 𝑗 ≠ 𝑗`  
Therefore, the bias associated with DeLong et al.’s SC variance estimator is: 
𝐸[𝑣𝑎?̂?(∆AUC)̂ ] − 𝑣𝑎𝑟(∆𝐴𝑈?̂?) =  
𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗] − 𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖`𝑗] − 𝑐𝑜𝑣[𝛿𝑖𝑗,𝛿𝑖𝑗`]
𝑚𝑛
, 𝑖 ≠ 𝑖`, 𝑗 ≠ 𝑗`. 
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Appendix D 
 
The following proves that the U-statistics variance estimator is unbiased. 
 
Starting with: 
var(∆AUĈ) = var(
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
) 
and using the property of expectations for the variance of a discrete random variable X, 
var(X)=E(X2) – (E(X))2, we get 
var(∆AUĈ) = E(
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
2
) − (𝐸 (
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
))
2
 
First solving for the first part of the above equation, we get: 
E(
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
2
) = 𝐸 (
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
∗
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
) 
        = E((𝐴𝑈𝐶1̂ − 𝐴𝑈𝐶2)̂  * (𝐴𝑈𝐶1̂ − 𝐴𝑈𝐶2)̂ ) 
        = E((𝐴𝑈𝐶1̂ − 𝐴𝑈𝐶2)̂
2) 
        = (𝐴𝑈𝐶1 − 𝐴𝑈𝐶2)
2 
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Now solving for the second part of the above equation, we get: 
(𝐸 (
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
))
2
= 𝐸 (
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
) ∗ 𝐸 (
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗
𝑛
𝑗=1
𝑚
𝑖=1
). 
𝐿𝑒𝑡 𝛾 =
1
𝑚𝑛
∑∑ 𝛿𝑖𝑗 ∗
1
(𝑚 − 1)(𝑛 − 1)
∑ ∑  𝛿𝑖`𝑗`
𝑛
𝑗`=1
𝑗`≠𝑗
𝑚
𝑖`=1
𝑖`≠𝑖
 ,
𝑛
𝑗=1
𝑚
𝑖=1
 
𝑇ℎ𝑒𝑛, 𝐸(𝛾) =
1
𝑚𝑛
∑∑𝐸
𝑛
𝑗=1
𝑚
𝑖=1
[
 
 
 
 
𝛿𝑖𝑗 ∗
1
(𝑚 − 1)(𝑛 − 1)
∑ ∑  𝛿𝑖`𝑗`
𝑛
𝑗`=1
𝑗`≠𝑗
𝑚
𝑖`=1
𝑖`≠𝑖 ]
 
 
 
 
. 
Because 𝛿𝑖𝑗 and 𝛿𝑖`𝑗` are independent since i`≠i and j`≠j, the independence property 
E(XY)=E(X)E(Y) applies to the above expectation 𝐸(?̂?) and so we are left with: 
𝐸(𝛾) =
1
𝑚𝑛
∑∑𝐸
𝑛
𝑗=1
𝑚
𝑖=1
[𝛿𝑖𝑗] ∗ 𝐸
[
 
 
 
 
1
(𝑚 − 1)(𝑛 − 1)
∑ ∑  𝛿𝑖`𝑗`
𝑛
𝑗`=1
𝑗`≠𝑗
𝑚
𝑖`=1
𝑖`≠𝑖 ]
 
 
 
 
. 
=
1
𝑚𝑛
∑∑((1 ∗ P(X𝑖 < Y𝑗)
𝑛
𝑗=1
𝑚
𝑖=1
) + (1 2⁄ P(𝑋𝑖 = 𝑌𝑗))) − ((1 ∗ P(𝑈𝑖 < 𝑉𝑗)) + (
1
2⁄ P(𝑈𝑖 = 𝑉𝑗))) ∗ (𝐴𝑈𝐶`1 − 𝐴𝑈𝐶`2) 
Now using the expectation property for a continuous r.v. X, E(X)=∑𝑥𝑓(𝑥), we get: 
𝛾 = (𝑚𝑛)
1
𝑚𝑛
((P(𝑋 < 𝑌) + 1 2⁄ 𝑃(𝑋 = 𝑌)) − (P(𝑈 < 𝑉) +
1
2⁄ 𝑃(𝑈 = 𝑉))) ∗ (𝐴𝑈𝐶`1 − 𝐴𝑈𝐶`2) 
=(𝐴𝑈𝐶1 − 𝐴𝑈𝐶2)*( 𝐴𝑈𝐶`1 − 𝐴𝑈𝐶`2) 
=(𝐴𝑈𝐶1 − 𝐴𝑈𝐶2)
2 
Therefore, 𝛾 is an unbiased estimator for (𝐴𝑈𝐶1 − 𝐴𝑈𝐶2)
2.  
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Appendix E 
 
The following shows the normal distributions from which the healthy and diseased 
subject’s biomarkers (random variables) were simulated. 
 
We know that if X~N(µ, σ2), then Z = 
𝑋−µ
𝜎
 ~ N(0,1). Given that the healthy population is 
H~N(µH, 𝜎𝐻
2), we convert the normal distribution H into the standard normal by HT = 
𝐻− µ𝐻
𝜎𝐻
. 
This can be shown through the following:  
E(HT) = E(
𝐻−µ𝐻
𝜎𝐻
) = 
1
𝜎𝐻
 (E(H) -µ𝐻) = 
1
𝜎𝐻
 (µ𝐻 − µ𝐻) = 0 
var(HT) = var(
𝐻−µ𝐻
𝜎𝐻
) = 
1
𝜎𝐻
2  (var(H) + var(µ𝐻)) = 
1
𝜎𝐻
2  (𝜎𝐻
2 + 0) = 1 
∴ HT~N(0,1) 
 
Now given that the diseased population is D~N(µD, 𝜎𝐷
2), we simulate based on DT|H = 
𝐷− µ𝐻
𝜎𝐻
 
, which gives us the following: 
E(DT|H) = E(
𝐷−µ𝐻
𝜎𝐻
) = 
1
𝜎𝐻
 (E(D) -µ𝐻) = 
1
𝜎𝐻
 (µ𝐷 − µ𝐻) =  
µ𝐷−µ𝐻
𝜎𝐻
 
var(DT|H) = var(
𝐷−µ𝐻
𝜎𝐻
) = 
1
𝜎𝐻
2  (var(D) + var(µ𝐻)) = 
1
𝜎𝐻
2  (𝜎𝐷
2 + 0) =  
𝜎𝐷
2
𝜎𝐻
2  
∴ DT|H~N( 
µ𝑫−µ𝑯
𝜎𝐻
, 
𝝈𝑫
𝟐
𝝈𝑯
𝟐 ) 
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Appendix F 
 
R code for comparing two correlated AUCs: DeLong versus U-statistic approach 
 
compareAUC = function(outcome, x1, x2, method=" ") {       ## outcome has to be 0 or 1, two 
scores x1 and x2 
  x=x1[outcome==0]; y=x1[outcome==1]; 
  u=x2[outcome==0]; v=x2[outcome==1]; 
  kern_func = function(a,b) (sign(b-a)+1)/2  ## AUC kernel diff 
  Kdiff = outer(x,y,kern_func) - outer(u,v,kern_func) 
  m=nrow(Kdiff); n=ncol(Kdiff); 
  AUC_diff = mean(Kdiff) 
   
  if (method=="Ustats")  
    varAUC_diff = AUC_diff^2 - mean(mapply(function(i,j) Kdiff[i,j]*mean(Kdiff[-i,-
j]),rep(1:m,each=n),rep(1:n,times=m))) 
  if (method=="DeLong")   
    varAUC_diff = var(rowMeans(Kdiff))/m + var(colMeans(Kdiff))/n 
  z = AUC_diff/sqrt(varAUC_diff) 
  return(list(varAUC_diff=varAUC_diff, AUC_diff=AUC_diff,z=z,pval=(1-pnorm(abs(z)))*2)) 
} 
 
#Template for outputting the result 
N=n  #Choose sample size 
set.seed(1) 
#Healthy Population 
x=rnorm(N,mean=,sd=)  #Vary mean and SD 
u=rnorm(N,mean=,sd=) 
#Diseased Population 
y=rnorm(N,mean=,sd=) 
v=rnorm(N,mean=,sd=) 
 
compareAUC(outcome=c(rep(0,each=N),rep(1,each=N)),x1=c(x,y),x2=c(u,v),method="DeLong
") 
 
compareAUC(outcome=c(rep(0,each=N),rep(1,each=N)),x1=c(x,y),x2=c(u,v),method="Ustats") 
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Appendix G 
 
R code for Calculating Relative Bias, Relative RMSE, Empirical Type 1 Error rates and 
Empirical Power for Comparing two correlated AUCs: DeLong versus U-statistic approach 
 
The following code corresponds to Tables 1 and 7 only. To produce different simulation 
scenarios, vary the means, sample sizes, standard deviations, and correlation coefficients. 
 
library(mvtnorm) 
sim_num=10000 
delong=matrix(NA,sim_num,1) 
ustat=matrix(NA,sim_num,1) 
dif=matrix(NA,sim_num,1) 
delong_p=matrix(NA,sim_num,1) 
ustat_p=matrix(NA,sim_num,1) 
 
#output the 10,000 variance estimates for delong and ustat method, as well as the difference in 
AUC 
result = function(NH, ND, meanH, meanD, sigmaH, sigmaD) { 
  delong_p=ustat_p=numeric(sim_num) #initialize each time to get a clean vector 
  for(i in 1:sim_num) { 
    #healthy population (x and u) 
    xu=rmvnorm(n=NH, mean=meanH, sigma=sigmaH) 
    #diseased population (y and v) 
    yv=rmvnorm(n=ND, mean=meanD, sigma=sigmaD) 
#Estimates 
delong[i]=compareAUC(outcome=c(rep(0,each=NH),rep(1,each=ND)),x1=c(xu[,1],yv[,1]),x2=c
(xu[,2],yv[,2]),method="DeLong")$varAUC_diff 
ustat[i]=compareAUC(outcome=c(rep(0,each=NH),rep(1,each=ND)),x1=c(xu[,1],yv[,1]),x2=c(x
u[,2],yv[,2]),method="Ustats")$varAUC_diff 
dif[i]=compareAUC(outcome=c(rep(0,each=NH),rep(1,each=ND)),x1=c(xu[,1],yv[,1]),x2=c(xu[
,2],yv[,2]),method="DeLong")$AUC_diff 
delong_p[i]=compareAUC(outcome=c(rep(0,each=NH),rep(1,each=ND)),x1=c(xu[,1],yv[,1]),x2
=c(xu[,2],yv[,2]),method="DeLong")$pval 
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ustat_p[i]=compareAUC(outcome=c(rep(0,each=NH),rep(1,each=ND)),x1=c(xu[,1],yv[,1]),x2=c
(xu[,2],yv[,2]),method="Ustats")$pval 
} 
  #MC true variance from the AUC differences 
  MC_var=var(dif) 
  #column bind the variance estimates with the true variance estimate 
  delong=matrix(cbind(delong,rep(MC_var,sim_num)),sim_num,2) 
  ustat=matrix(cbind(ustat,rep(MC_var,sim_num)),sim_num,2) 
  #Calculate Bias 
  delongB=delong[,1]-delong[,2] 
  ustatB=ustat[,1]-ustat[,2] 
  D_Bias=mean(delongB) 
  U_Bias=mean(ustatB) 
  #Relative Bias 
  RD_Bias=(D_Bias/MC_var)*100 
  RU_Bias=(U_Bias/MC_var)*100 
  #Calculate RMSE 
  delongR=(delong[,1]-delong[,2])^2 
  ustatR=(ustat[,1]-ustat[,2])^2 
  D_RMSE=sqrt(mean(delongR)) 
  U_RMSE=sqrt(mean(ustatR)) 
  #Relative RMSE 
  RD_RMSE=(D_RMSE/MC_var)*100 
  RU_RMSE=(U_RMSE/MC_var)*100 
  #exclude NA when calculating the type I error/power 
  delong_power=mean(delong_p < 0.05,na.rm=T) 
  ustat_power=mean(ustat_p < 0.05,na.rm=T) 
return(list(RD_Bias=RD_Bias,RD_RMSE=RD_RMSE,RU_Bias=RU_Bias,RU_RMSE=RU_R
MSE,delong_power=delong_power,ustat_power=ustat_power)) 
} 
 
 
#1:1  
set.seed(1) 
v<-seq(10,30, by=5) 
res11=matrix(NA,5,6) 
res15=matrix(NA,5,6) 
res19=matrix(NA,5,6) 
res21=matrix(NA,5,6) 
res25=matrix(NA,5,6) 
res29=matrix(NA,5,6) 
res31=matrix(NA,5,6) 
res35=matrix(NA,5,6) 
res39=matrix(NA,5,6) 
for (n_i in seq(v)){ 
  n=v[n_i] 
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#Section 1 
  res11[n_i,]<-as.numeric(c(result(NH=n, ND=n, meanH=rep(0,2), meanD=rep(1.8124,2), 
sigmaH=matrix(c(1,0.1,0.1,1),2,2), sigmaD=matrix(c(1,0.1,0.1,1),2,2)))) 
  res15[n_i,]<-as.numeric(c(result(NH=n, ND=n, meanH=rep(0,2), meanD=rep(1.8124,2), 
sigmaH=matrix(c(1,0.5,0.5,1),2,2), sigmaD=matrix(c(1,0.5,0.5,1),2,2)))) 
  res19[n_i,]<-as.numeric(c(result(NH=n, ND=n, meanH=rep(0,2), meanD=rep(1.8124,2), 
sigmaH=matrix(c(1,0.9,0.9,1),2,2), sigmaD=matrix(c(1,0.9,0.9,1),2,2)))) 
   
#Section 2 
  res21[n_i,]<-as.numeric(c(result(NH=n, ND=n, meanH=rep(0,2), meanD=c(1.8124,2.2049), 
sigmaH=matrix(c(1,0.1,0.1,1),2,2), sigmaD=matrix(c(1,0.14,0.14,1.96),2,2)))) 
  res25[n_i,]<-as.numeric(c(result(NH=n, ND=n, meanH=rep(0,2), meanD=c(1.8124,2.2049), 
sigmaH=matrix(c(1,0.5,0.5,1),2,2), sigmaD=matrix(c(1,0.7,0.7,1.96),2,2)))) 
  res29[n_i,]<-as.numeric(c(result(NH=n, ND=n, meanH=rep(0,2), meanD=c(1.8124,2.2049), 
sigmaH=matrix(c(1,0.9,0.9,1),2,2), sigmaD=matrix(c(1,1.26,1.26,1.96),2,2))))  
   
#Section 3 
  res31[n_i,]<-as.numeric(c(result(NH=n, ND=n, meanH=rep(0,2), meanD=c(1.8124,1.5643), 
sigmaH=matrix(c(1,0.1,0.1,1),2,2), sigmaD=matrix(c(1,0.07,0.07,0.49),2,2))))  
  res35[n_i,]<-as.numeric(c(result(NH=n, ND=n, meanH=rep(0,2), meanD=c(1.8124,1.5643), 
sigmaH=matrix(c(1,0.5,0.5,1),2,2), sigmaD=matrix(c(1,0.35,0.35,0.49),2,2))))  
  res39[n_i,]<-as.numeric(c(result(NH=n, ND=n, meanH=rep(0,2), meanD=c(1.8124,1.5643), 
sigmaH=matrix(c(1,0.9,0.9,1),2,2), sigmaD=matrix(c(1,0.63,0.63,0.49),2,2))))  
} 
results<-cbind(res11, res15, res19, res21, res25, res29, res31, res35, res39) 
 
 
#1:2 
v<-seq(20,60, by=10) 
res11=matrix(NA,5,6) 
res15=matrix(NA,5,6) 
res19=matrix(NA,5,6) 
res21=matrix(NA,5,6) 
res25=matrix(NA,5,6) 
res29=matrix(NA,5,6) 
res31=matrix(NA,5,6) 
res35=matrix(NA,5,6) 
res39=matrix(NA,5,6) 
for (n_i in seq(v)){ 
  n=v[n_i] 
   
 
 
 
 
 47 
#Section 1 
  res11[n_i,]<-as.numeric(c(result(NH=round(n/3), ND=n-round(n/3), meanH=rep(0,2), 
meanD=rep(1.8124,2), sigmaH=matrix(c(1,0.1,0.1,1),2,2), sigmaD=matrix(c(1,0.1,0.1,1),2,2)))) 
  res15[n_i,]<-as.numeric(c(result(NH=round(n/3), ND=n-round(n/3), meanH=rep(0,2), 
meanD=rep(1.8124,2), sigmaH=matrix(c(1,0.5,0.5,1),2,2), sigmaD=matrix(c(1,0.5,0.5,1),2,2)))) 
  res19[n_i,]<-as.numeric(c(result(NH=round(n/3), ND=n-round(n/3), meanH=rep(0,2), 
meanD=rep(1.8124,2), sigmaH=matrix(c(1,0.9,0.9,1),2,2), sigmaD=matrix(c(1,0.9,0.9,1),2,2)))) 
   
#Section 2 
  res21[n_i,]<-as.numeric(c(result(NH=round(n/3), ND=n-round(n/3), meanH=rep(0,2), 
meanD=c(1.8124,2.2049), sigmaH=matrix(c(1,0.1,0.1,1),2,2), 
sigmaD=matrix(c(1,0.14,0.14,1.96),2,2)))) 
  res25[n_i,]<-as.numeric(c(result(NH=round(n/3), ND=n-round(n/3), meanH=rep(0,2), 
meanD=c(1.8124,2.2049), sigmaH=matrix(c(1,0.5,0.5,1),2,2), 
sigmaD=matrix(c(1,0.7,0.7,1.96),2,2)))) 
  res29[n_i,]<-as.numeric(c(result(NH=round(n/3), ND=n-round(n/3), meanH=rep(0,2), 
meanD=c(1.8124,2.2049), sigmaH=matrix(c(1,0.9,0.9,1),2,2), 
sigmaD=matrix(c(1,1.26,1.26,1.96),2,2))))  
  
 #Section 3 
  res31[n_i,]<-as.numeric(c(result(NH=round(n/3), ND=n-round(n/3), meanH=rep(0,2), 
meanD=c(1.8124,1.5643), sigmaH=matrix(c(1,0.1,0.1,1),2,2), 
sigmaD=matrix(c(1,0.07,0.07,0.49),2,2))))  
  res35[n_i,]<-as.numeric(c(result(NH=round(n/3), ND=n-round(n/3), meanH=rep(0,2), 
meanD=c(1.8124,1.5643), sigmaH=matrix(c(1,0.5,0.5,1),2,2), 
sigmaD=matrix(c(1,0.35,0.35,0.49),2,2))))  
  res39[n_i,]<-as.numeric(c(result(NH=round(n/3), ND=n-round(n/3), meanH=rep(0,2), 
meanD=c(1.8124,1.5643), sigmaH=matrix(c(1,0.9,0.9,1),2,2), 
sigmaD=matrix(c(1,0.63,0.63,0.49),2,2))))  
} 
results1<-cbind(res11, res15, res19, res21, res25, res29, res31, res35, res39) 
 
 
#1:3 
v<-seq(20,60, by=10) 
res11=matrix(NA,5,6) 
res15=matrix(NA,5,6) 
res19=matrix(NA,5,6) 
res21=matrix(NA,5,6) 
res25=matrix(NA,5,6) 
res29=matrix(NA,5,6) 
res31=matrix(NA,5,6) 
res35=matrix(NA,5,6) 
res39=matrix(NA,5,6) 
for (n_i in seq(v)){ 
  n=v[n_i] 
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#Section 1 
  res11[n_i,]<-as.numeric(c(result(NH=round(n/4), ND=n-round(n/4), meanH=rep(0,2), 
meanD=rep(1.8124,2), sigmaH=matrix(c(1,0.1,0.1,1),2,2), sigmaD=matrix(c(1,0.1,0.1,1),2,2)))) 
  res15[n_i,]<-as.numeric(c(result(NH=round(n/4), ND=n-round(n/4), meanH=rep(0,2), 
meanD=rep(1.8124,2), sigmaH=matrix(c(1,0.5,0.5,1),2,2), sigmaD=matrix(c(1,0.5,0.5,1),2,2)))) 
  res19[n_i,]<-as.numeric(c(result(NH=round(n/4), ND=n-round(n/4), meanH=rep(0,2), 
meanD=rep(1.8124,2), sigmaH=matrix(c(1,0.9,0.9,1),2,2), sigmaD=matrix(c(1,0.9,0.9,1),2,2)))) 
   
#Section 2 
  res21[n_i,]<-as.numeric(c(result(NH=round(n/4), ND=n-round(n/4), meanH=rep(0,2), 
meanD=c(1.8124,2.2049), sigmaH=matrix(c(1,0.1,0.1,1),2,2), 
sigmaD=matrix(c(1,0.14,0.14,1.96),2,2)))) 
  res25[n_i,]<-as.numeric(c(result(NH=round(n/4), ND=n-round(n/4), meanH=rep(0,2), 
meanD=c(1.8124,2.2049), sigmaH=matrix(c(1,0.5,0.5,1),2,2), 
sigmaD=matrix(c(1,0.7,0.7,1.96),2,2)))) 
  res29[n_i,]<-as.numeric(c(result(NH=round(n/4), ND=n-round(n/4), meanH=rep(0,2), 
meanD=c(1.8124,2.2049), sigmaH=matrix(c(1,0.9,0.9,1),2,2), 
sigmaD=matrix(c(1,1.26,1.26,1.96),2,2))))  
  
 #Section 3 
  res31[n_i,]<-as.numeric(c(result(NH=round(n/4), ND=n-round(n/4), meanH=rep(0,2), 
meanD=c(1.8124,1.5643), sigmaH=matrix(c(1,0.1,0.1,1),2,2), 
sigmaD=matrix(c(1,0.07,0.07,0.49),2,2))))  
  res35[n_i,]<-as.numeric(c(result(NH=round(n/4), ND=n-round(n/4), meanH=rep(0,2), 
meanD=c(1.8124,1.5643), sigmaH=matrix(c(1,0.5,0.5,1),2,2), 
sigmaD=matrix(c(1,0.35,0.35,0.49),2,2))))  
  res39[n_i,]<-as.numeric(c(result(NH=round(n/4), ND=n-round(n/4), meanH=rep(0,2), 
meanD=c(1.8124,1.5643), sigmaH=matrix(c(1,0.9,0.9,1),2,2), 
sigmaD=matrix(c(1,0.63,0.63,0.49),2,2))))  
} 
results2<-cbind(res11, res15, res19, res21, res25, res29, res31, res35, res39) 
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